Talking points for physicians, patients and caregivers considering Aduhelm ® infusion and the accelerated pathway for its approval by the FDA
Source: Molecular Neurodegeneration - Category: Neurology Authors: Sam Gandy, David S. Knopman and Mary Sano Tags: Commentary Source Type: research